Navigation Links
John Theurer Cancer Center researchers shed light on new multiple myeloma therapy
Date:7/25/2012

HACKENSACK, N.J. (July 25, 2012) Researchers from John Theurer Cancer Center at HackensackUMC, one of the nation's 50 best hospitals for cancer, played leading roles in three separate multi-center studies with the new proteasome inhibitor carfilzomib published in Blood, a major peer-reviewed scientific journal.

Carfilzomib is a novel, highly selective proteasome inhibitor, a type of medication that blocks the actions of certain proteins (proteasomes) that cancer cells need to survive and multiply. Carfilzomib is also known by its branded name Kyprolis.

On July 20th the U.S. Food and Drug Administration (FDA) approved Kyprolis (carfilzomib) as a new treatment for advanced multiple myeloma. The treatment was fast-tracked due to the unmet need in multiple myeloma.

The most recent Blood study, published online today, includes results from the open-label, single arm phase IIb 003-A1 study of single-agent carfilzomib for patients with relapsed and refractory multiple myeloma. Carfilzomib's New Drug Application (NDA) is based primarily on this study. This research, along with the two other Blood studies, may change the way multiple myeloma is managed for newly diagnosed and relapsed/refractory patients.

Phase IIb Clinical Trial Published in Blood

David S. Siegel, M.D., Ph.D., Chief, Multiple Myeloma was the lead investigator of this pivotal multi-center, phase IIb study involving 30 cancer centers in the United States and Canada. The trial evaluated 266 heavily-pretreated patients with relapsed and refractory multiple myeloma who had received at least two prior therapies, including bortezomib and either thalidomide or lenalidomide.

"We found that carfilzomib produced clinically significant responses with an acceptable safety profile in heavily pretreated patients with relapsed and refractory multiple myeloma," said Dr. Siegel. "Given the limited number of treatment options
'/>"/>

Contact: Amy Leahing
aleahing@p4strategy.com
305-458-0599
John Theurer Cancer Center
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Experts from John Theurer Cancer Center to participate in the AAMDSIF Patient and Family Conference
2. John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium
3. New probe provides vital assist in brain cancer surgery
4. Researchers find driver of breast cancer stem cell metastasis
5. Novel pig model may be useful for human cancer studies
6. Colonoscopy screening markedly reduces colorectal cancer incidence and death
7. A new route for tackling treatment-resistant prostate cancer
8. Antioxidants Might Help Cut Pancreatic Cancer Risk, Study Suggests
9. Young Cancer Patients Often Lack Support: Study
10. Media alert: 24th EORTC - NCI - AACR Symposium Molecular Targets and Cancer Therapeutics
11. Tel Aviv University research links childhood obesity to cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... ... is an unavoidable result of incision or injury to the skin. Unsightly as it may ... appearance of a scar is dependent on many factors – the size and depth of ... to near invisibility on their own over a period of months,” says Dr. Jocelyn ...
(Date:9/3/2015)... ... , ... “Love in Tokyo” an independent romantic comedy film by Michael Solton ... and will be released on DVD early next year, by Maverick Entertainment. The film ... and singer/songwriter, and Jason London, lead from “Dazed and Confused.” , “Love in ...
(Date:9/3/2015)... ... 2015 , ... Representatives with State Farm Agent EJ Roberts ... Gulf Babypalooza on September 19, 2015. , “We will be providing information to ... We will be discussing setting up college funds, offering information specific to their ...
(Date:9/3/2015)... ... September 03, 2015 , ... At Renew Man™, we have seen ... traditional health care model, where the primary care physician dictates and the patient obeys. ... become educated about their health issues and empowered to choose their own treatment options. ...
(Date:9/3/2015)... ... 03, 2015 , ... About 220,800 new cases of prostate cancer are reported each year, along ... with prostate cancer during their lifetime. While only one man in 10,000 will typically get ... age 65, according to the American Cancer Society. , Prostate cancer ...
Breaking Medicine News(10 mins):Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 3
... Care Physician Recruitment, ORLANDO, Fla., Nov. 10 ... - with primary care,being especially hard hit. As the ... shortage promises to get worse with major,repercussions for the ... working to address this issue with a new policy ...
... - BELLUS Health Inc. (NASDAQ:,BLUS; TSX: BLU) reports ... For the three-month period ended September 30, 2008, ... compared to $13,889,000 ($0.29,per share) for the corresponding ... September 30, 2008, the net loss amounted to,$36,703,000 ...
... Adds Fuel to Double-Digit Growth in Europe, PROVO, ... (NYSE: NUS ) opened for business in the ... adds further fuel to the,company,s increasingly successful European region., ... the,Czech Republic is becoming a dynamic market for direct ...
... 10 Medipacs, Inc., a Tucson based,drug delivery ... and Agustin Vilches, RPh to the company,s medical ... and together have practiced,in Hospital, Hospice and Home ... years at Swedish Hospital Medical,Center and the Fred ...
... and Address Vital Breast Cancer Health ... Care Issues for All Illinois Residents, SPRINGFIELD, Ill., Nov. 10 ... of the global breast cancer movement,will convene at the first-ever Komen ... state,s breast health coverage, discuss,the impact of statewide breast health programs ...
... Nov. 10 Jazz,Pharmaceuticals, Inc. (Nasdaq: JAZZ ) ... results on November 13, 2008, before the open,of U.S. ... and live audio webcast to discuss the results and ... Time/5:30 a.m. Pacific,Time., The live webcast and press ...
Cached Medicine News:Health News:AMA Works to Reverse Primary Care Physician Shortage 2Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 2Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 3Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 4Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 5Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 6Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 7Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 8Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 9Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 10Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 11Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 12Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 13Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 14Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 15Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 16Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 17Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 18Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 19Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 20Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 21Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 22Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 23Health News:Nu Skin Enterprises Opens the Czech Republic 2Health News:Medipacs Appoints Advisory Board Members 2Health News:Susan G. Komen for the Cure(R) Hosts Inaugural Illinois State Summit in Springfield 2Health News:Jazz Pharmaceuticals, Inc. to Announce Third Quarter Financial Results on November 13, 2008 2
(Date:9/2/2015)... YORK , Sept. 2, 2015 ... by the collapse of one or more vertebral ... patients. Osteoporosis, a degenerative bone disease, is a ... bone disease, multiple myeloma, metastatic spinal tumors, and ... can undergo vertebroplasty and kyphoplasty to rectify the ...
(Date:9/2/2015)... Sept. 2, 2015  The report on breast cancer ... breast cancer drugs on the basis of the molecules ... from the inner lining of milk ducts or lobules ... type of tumor that can spread to other cells ... starts in lobules is referred as lobular carcinoma, while ...
(Date:9/2/2015)... -- About Neuroendovascular Coil A ... and ruptured brain aneurysm (a weakened area in ... as an endovascular coiling or endovascular embolization. During ... flow in an aneurysm. The endovascular coiling treatment ... interventional neuroradiologist using fluoroscopic imaging guidance. Neuroendovascular coils ...
Breaking Medicine Technology:Global Balloon Kyphoplasty Market 2015-2019 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Global Neuroendovascular Coil Market 2015-2019 2
... VIA Pharmaceuticals,Inc. (Nasdaq: VIAP ), a biotechnology ... treatment of cardiovascular disease, announced today that,it will ... results of the,VIA-2291 Phase 2 acute coronary syndrome ... American Heart Association (AHA) Scientific,Sessions 2008 on Sunday, ...
... Nov. 5 Medarex, Inc.,(Nasdaq: MEDX ) ... payment of,an undisclosed amount from its licensing partner, ... 2 trial of CNTO 95, a fully human ... tumor-induced,angiogenesis. The CNTO 95 human antibody was generated ...
Cached Medicine Technology:VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA 2Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors 2
... ergonomics, and value!, Comfortable feel ... non-slip, contoured handle , Finer control ... spring action , Completely autoclavable for ... need for recalibration , Easy-to-read precision ...
... the range from 2ul to 5000ul. Fills ... design prevents inadvertent volume change. Novel hand ... pipette is autoclavable at 121C(250F). To prevent ... Suitable for one-handed operation. Auto or Normal ...
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 0.5-10 microliter range....
... Focus from Thermo Labsystems was designed specifically ... Advanced features such as the new fast ... on microvolumes help to define this as ... The new interchangeable handle plate offers a ...
Medicine Products: